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analysis and interpretation.Previous research indicated that ZAP70, a Syk family tyrosine kinase, is expressed in mouse embry-
onic stem cells (mESCs) and regulates the Janus kinase 1 (JAK1)/signal transducer and activator of
transcription 3 (STAT3) signaling through consolidating SHP1 enzymatic activity. In this study, we
report that SHP2 is another downstream target of ZAP70 in mESCs. We found that SHP2 phosphor-
ylation and enzymatic activity are affected by Zap70 expression. In addition, we present evidence
that ERK pathways activated by ZAP70 and SHP2 reduce the protein level of leukemia inhibitory fac-
tor (LIF) receptor. Based on these results, we propose that SHP2 is an essential mediator of the ZAP70
signal to regulate JAK1/STAT3 and ERK pathways in undifferentiated mESCs.
 2010 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Intracellular signal transduction pathways are essential for
mouse embryonic stem cells (mESCs) grown in the presence of leu-
kemia inhibitory factor (LIF) to maintain an undifferentiated, self-
renewing state of the cells [1]. LIF promotes the proliferation of
undifferentiated stem cells through the activation of a heteromeric
complex containing two related cytokine receptor subunits, gp130
and LIF receptor (LIFR) [2,3]. One of the most important pathways
activated by LIF in mESCs is the Janus kinase 1 (JAK1)/signal trans-
ducer and activator of transcription 3 (STAT3) pathway [4,5]. Phos-
phorylation and dephosphorylation of JAK1 and STAT3 plays a
central role in controlling the activity of the pathway. The majority
of phosphorylation and dephosphorylation occurs at tyrosine resi-
dues and is carried out by protein tyrosine kinases and protein
tyrosine phosphatases, respectively [4,6]. The Ras-Raf-mitogen
activated protein kinase (MEK)-extracellular signal-regulated ki-
nase (ERK) signaling cascade is another important pathway in
ESCs. Stimulation of ERK1 and ERK2 is known to be of particular
importance in inducing differentiation of mESCs [7,8]. The plurip-
otent state of ESCs is maintained by the balance between self re-chemical Societies. Published by E
assembly of data.
gn, manuscript writing, datanewal regulated by JAK1/STAT3 and differentiation potential
regulated by the ERK pathway [7]. Therefore, a functional analysis
of signals transduced through the JAK1/STAT3 and ERK pathways
provides an opportunity to elucidate the molecular mechanisms
that regulate stemness of ESCs.
Src homology region 2 domain-containing phosphatase 2
(SHP2) is a cytoplasmic phospho-tyrosine phosphatase with two
Src-homology 2 (SH2) domains at the N-terminus that modulates
signal strength downstream of cytokine/growth factor receptors
[9,10]. In mESCs, SHP2 appears to negatively regulate the activity
of STAT3. Shp2D/Dmutant mESCs showed defective differentiation
and more efﬁcient self-renewal in the presence of LIF, which was at
least in part due to increased STAT3 activity in the absence of func-
tional SHP2 [11,12]. In contrast to the phospho-STAT3 signal, the
LIF-stimulated phospho-ERKs level is decreased in SHP2-deﬁcient
mESCs compared to wild-type cells [11,12], which suggests that
SHP2 has a reciprocal role in modulating LIF-stimulated ERK and
STAT3 pathways in mESCs. Furthermore, the function of SHP2 to
regulate pluripotency and differentiation of mESCs is conserved
with hESCs, despite that LIF is not required for hESC self-renewal
[13].
ZAP70, a Syk family tyrosine kinase, has been reported to be
present exclusively in normal T cells and natural killer (NK) cells,
serving as a pivotal regulator of antigen-mediated receptor signal-
ing [14]. A recent study suggested that Zap70 is expressed in
mESCs and functions as a key upstream regulator of JAK1/STAT3
signaling in the cells [15]. In particular, ZAP70 modulates SHP1lsevier B.V. All rights reserved.
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LIF-stimulated culture conditions [15]. In this study, for the ﬁrst
time to our knowledge, we report that ZAP70 regulates SHP2 activ-
ity in undifferentiated mESCs. We demonstrate that SHP2 is a
mediator of the ZAP70 signal to regulate JAK1/STAT3 and ERK
pathways in mESCs. Furthermore, ERKs activity regulated by
ZAP70 and SHP2 signal modulates LIFR protein level in mESCs.2. Materials and methods
2.1. Cell culture and transfection
J1 mESCs (cat # SCRC-1010) were purchased from ATCC
(www.atcc.org). Zap70 knocked down mESC (Zap70KD) were gen-
erated as described previously [15]. mESCs were cultured in Dul-
becco’s Modiﬁed Eagle’s Medium (DMEM) supplemented with
15% fetal calf serum (Hyclone), 0.1 mM 2-mercaptoethanol (Sig-
ma), 100 U/ml penicillin, 100 lg/ml streptomycin, 2 mM gluta-
mine (Gibco) and 1000 U/ml LIF (Chemicon). For transient
knockdown of Zap70 and Shp2, ON-TARGET plus siRNA mixture
(Dharmacon) for each gene was transfected into mESCs as de-
scribed previously [15].
2.2. RNA isolation and cDNA synthesis
Total RNA was extracted using TRIzol (Invitrogen), and 2–5 lg
of total RNA was reverse-transcribed using the SuperScriptII™
First-Strand Synthesis System (Invitrogen) according to the manu-
facturer’s instructions.
2.3. Protein extraction and immunoblot
Immunoblotting was performed as previously described [16].
The following antibodies were used: STAT3 (sc-482, Santa Cruz),
phospho-STAT3 (Tyr-705) (#9131, Cell Signaling), ERKs (sc-154,
Santa Cruz), phospho-ERKs (Thr 202/Tyr 204, Sigma), SHP2 (sc-
280, Santa Cruz), phospho-SHP2 (#3703, Cell Signaling), c-MYC
(sc-764, Santa Cruz), LIFR (sc-659, Santa Cruz), and b-actin (sc-
47778, Santa Cruz). Immunoreactivity was detected by enhanced
chemiluminescence (Amersham, Buckinghamshire, England). For
quantitative analysis, the mean density of each band was mea-
sured with Multi Gauge V3.0 software, and the band density of
phospho-SHP2 and phospho-ERKs was divided by the density of
the corresponding total protein band to obtain the normalized
band density. The immunoblot band density of c-MYC and LIFR
was divided by that of b-actin.
2.4. Immunoprecipitation and phosphatase assay
Cell lysates containing 1 mg of protein were diluted to 500 ll
with lysis buffer and incubated with speciﬁc antibodies against
SHP2 or ZAP70 (Santa Cruz) overnight at 4 C. Immunocomplexes
were recovered by incubation with 20 ll of a 50% slurry of pro-
tein-A-conjugated Sepharose (Amersham Biosciences, Inc.) in PBS
for 4 h with agitation. Phosphatase activity was determined color-
imetrically using p-nitrophenylphosphate (pNPP; Sigma) as a sub-
strate. The rate of hydrolysis of pNPP was analyzed by measuring
the change in absorbance at 410 nm. Beads were washed twice
with cold PBS and boiled in SDS sample buffer, separated by
SDS–PAGE, and immunoblotted to detect the presence of SHP2.
2.5. Statistical analysis
Graphical data are presented as the means ± standard devia-
tions (S.Ds). Statistical signiﬁcance was determined using Student’st-test. Statistical analyses were performed using the SAS statistical
package v.9.13 (SAS Inc., Cary, NC, USA, http://www.sas.com/).3. Results
3.1. The effect of Zap70 suppression on the phosphorylation and
enzymatic activity of SHP2 in mESCs
Zap70 is expressed in mESCs and functions to maintain stem-
ness of mESCs by negatively regulating JAK1/STAT3 signaling
[15]. Because SHP2 is one of the known negative regulators of
Jak/STAT3 signaling [7], we hypothesized that SHP2 is a down-
stream target of ZAP70 in mESCs. To address this possibility, we
ﬁrst tested whether a chemical inhibitor of ZAP70 activity blocked
phosphorylation of Tyr580 in the C-terminal tail of SHP2, which is
positively related to the enzymatic activity of SHP2 [17]. As shown
in Fig. 1A, piceatannol, a potent Syk/ZAP70-speciﬁc tyrosine kinase
inhibitor [18], abrogated SHP2 Tyr580 phosphorylation gradually
in a concentration-dependent manner. Consistent with this ﬁnd-
ing, a signiﬁcantly lower level of phospho-SHP2 was observed in
Zap70 knocked down mESC cell line (Zap70KD) (Fig. 1B). SHP2
phosphorylation was also suppressed by the transient knockdown
of Zap70 (Fig. 1C). Based on the fact that SHP2 Tyr580 phosphory-
lation is directly related to the enzymatic activity of SHP2 [18], we
speculated that Zap70KD may exhibit altered SHP2 phosphatase
activity. In support of this idea, the enzymatic activity of SHP2,
immunoprecipitated from Zap70KD lysates, was signiﬁcantly re-
duced compared to that of the control (Fig. 1D).
3.2. The effect of Zap70 overexpression on the phosphorylation and
enzymatic activity of SHP2 in mESCs
The effects of Zap70 knockdown on the phosphorylation and
phosphatase activity of SHP2 suggest that the enzymatic activity
of SHP2 is regulated by the kinase activity of ZAP70 in mESCs. To
further substantiate this possibility, we over-expressed Zap70
transiently in mESCs (OE), and then analyzed phosphorylation
and enzymatic activity of SHP2. As expected, Zap70 overexpression
induced SHP2 Tyr580 phosphorylation (Fig. 2A). We found that
SHP2 activity in Zap70OE was signiﬁcantly increased compared
to the control cells (Fig. 2B). As reported previously, Zap70OE
shows reduced levels of STAT3 phosphorylation and c-MYC expres-
sion (Fig. 2C, left panel) [15]. When SHP2 expression was sup-
pressed by siRNA, the effect of ZAP70 toward both STAT3
phosphorylation and c-MYC expression was reverted (Fig. 2C, right
panel). Taken together, these results support the idea that SHP2
activity is affected by ZAP70 in mESCs, which subsequently leads
to regulation of the JAK1/STAT3 signaling pathway. Previously,
we reported that enzymatic activity of SHP1 is affected by ZAP70
in mESCs [15]. Therefore, our results suggest that the negative ef-
fect of ZAP70 on the JAK1/STAT3 pathway in mESCs is caused by
SHP2 in conjunction with SHP1 activity.
3.3. ZAP70 represses LIFR expression through the SHP2 and ERK
signaling pathways in mESCs
Zap 70 knockdown induces increased self-renewal of mESCs by
enhancing STAT3 signaling [15]. Because LIF-stimulated ERK and
STAT3 signals are ﬁnely tuned in opposite directions to maintain
the stemness of mESCs, we hypothesized that ZAP70 may activate
the ERK pathway in mESCs. To address this, we examined ERK
phosphorylation in mESCs following chemical inhibition of ZAP70
activity. As expected, the level of phospho-ERKs was decreased as
piceatannol concentration increased (Fig. 3A). On the contrary,
phospho-ERKs were increased upon Zap70 overexpression in
Fig. 1. The effect of Zap70 suppression on the phosphorylation and enzymatic activity of SHP2. (A) Piceatannol was added to the culture media of mESCs for 24 h at the
indicated concentrations. Total and phosphorylated SHP2 were analyzed by immunoblot. (B) Phosphorylation of SHP2 in Zap70 knockdown mESC cell line [15] was analyzed
by immunoblot. (C) Transient knockdown of Zap70 was induced by the transfection of siRNA targeting Zap70, and the phosphorylation of SHP2 was then analyzed by
immunoblot. (D) Total protein from control or Zap70 knocked down mESCs was immunoprecipitated by anti-SHP2 antibody and phosphatase activity was analyzed (top
panel). SHP2 protein level in immunoprecipitated samples was determined by immunoblot (bottom panel). * Indicates signiﬁcant (P < 0.05) and ** indicates highly signiﬁcant
(P < 0.01) results based on Student’s t-test. Error bars represent standard deviation from at least three independent experiments. In (B) and (C), Zap70 expression level was
analyzed by RT-PCR. Abbreviations: Pic, piceatannol; C, stable cell line of mESCs constructed by the genomic integration of non-speciﬁc shRNA plasmid; Zap70KD, stable cell
line of Zap70 knocked down mESCs; siZap70, siRNA targeting Zap70; siNS, non-speciﬁc siRNA; IP, immunoprecipitation; IB, immunoblot.
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with Zap70 expressing plasmid, the effect of ZAP70 on the phos-
phorylation of ERKs was abolished (Fig. 3C). This result implies that
the enhanced phosphorylation of ERKs in Zap70OE is caused by
SHP2 activity. Previously, we reported that the expression of LIFR
is signiﬁcantly upregulated in Zap70KD [15]. In neuroblastoma
cells, stimulation with epidermal growth factor or ﬁbroblast
growth factor decreases LIFR in an ERK1/2-dependent manner
and the downregulation is due to increased rates of lysosomal deg-
radation [19]. Likewise, the inhibition of ERK2 activity with U0126
induced an increase of LIFR protein in mESCs (Fig. 3D). Given that
phosphorylation of ERKs is regulated by the ZAP70 and SHP2 sig-
naling pathway, we examined whether the ZAP70 effect on LIFR
regulation is caused by SHP2 activity. As expected, Zap70 overex-
pression caused suppression of LIFR (Fig. 3E). However, when
Shp2 was knocked down by siRNA, the suppression effect ofZAP70 on the LIFR level was reversed (Fig. 3F). Taken together,
these results suggest that ZAP70 represses LIFR expression through
the activation of SHP2.
4. Discussion
SHP2 functions physiologically as a molecular switch governing
self-renewal versus differentiation in mESCs. It modulates LIF-
stimulated STAT3 and ERK signals bi-directionally [20]. In this
study, we suggest that ZAP70 is an upstream regulator of SHP2
phosphatase, which suppresses STAT3 phosphorylation and en-
hances ERK1/2 phosphorylation (Fig. 4). Furthermore, we suggest
that the ZAP70 and SHP2 pathway modulates LIFR expression via
the ERK1/2 pathway. Our Zap70OE and siShp2 analysis shows that
SHP2 and ERK1/2 activity is up-regulated by ZAP70, resulting in
the suppression of LIFR expression in mESCs. In neuroblastoma
Fig. 2. The effect of Zap70 overexpression on the phosphorylation and enzymatic activity of SHP2. (A) Zap70-expressing plasmid was transiently transfected into mESCs for
48 h, Zap70 expression was analyzed by RT-PCR and phosphorylation of SHP2 was analyzed by immunoblot. (B) Total protein of mESCs transfected with GFP or Zap70
expressing plasmid was immunoprecipitated by anti-SHP2 antibody and phosphatase activity was analyzed (right panel). SHP2 protein level in immunoprecipitated samples
was determined by immunoblot (left panel). (C) Total proteins of mESCs transfected with GFP or Zap70 expressing plasmid were analyzed for the phosphorylation of STAT3 or
c-MYC expression (left panel). Zap70 expressing plasmid was cotransfected with siNS or siShp2 into mESCs for 48 h. Phospho-STAT3, STAT3 and c-MYC expression were then
analyzed by immunoblot. * Indicates signiﬁcant (P < 0.05) and ** indicates highly signiﬁcant (P < 0.01) results based on Student’s t-test. Error bars represent standard
deviation from at least three independent experiments. Abbreviations: C, mESCs transfected with GFP expressing plasmid; Zap70OE, mESCs transfected with Zap70 expressing
plasmid; siShp2, siRNA targeting Shp2; siNS, non-speciﬁc siRNA; IP, immunoprecipitation; IB, immunoblot.
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depending on ERK1/2 activity as a negative mechanism [19].
Therefore, further investigation is required to demonstrate the
underlying mechanism of ZAP70 to regulate LIFR level in mESCs.Recently, it was reported that the function of SHP2 to regulate
differentiation of ES cells is conserved between mESCs and hESCs,
despite that the molecular mechanism to sustain self-renewal of
the two types of ES cells is different [13]. Since our preliminary
Fig. 3. ZAP70 represses LIFR expression through SHP2 in mESCs. (A) Piceatannol was added to the culture media of mESCs for 24 h at the indicated concentrations and
phospho-ERK1/2 level was analyzed by immunoblot. (B) Total proteins of mESCs transfected with GFP or Zap70 expressing plasmid were analyzed for ERK1/2
phosphorylation. (C) GFP or Zap70 expressing plasmid was cotransfected with siNS or siShp2 into mESCs for 48 h. phospho-ERK1/2 level was analyzed by immunoblot. (D) 0
or 2 lM of U0126 was added to the culture media of wild-type mESCs for 24 h and LIFR expression was analyzed by immunoblot. (E) GFP or Zap70 expressing plasmid was
transfected into mESCs for 48 h and LIFR level was analyzed by immunoblot. (F) GFP or Zap70 expressing plasmid was cotransfected with siNS or siShp2 into mESCs for 48 h
and LIFR level was analyzed by immunoblot. * Indicates signiﬁcant (P < 0.05) and ** indicates highly signiﬁcant (P < 0.01) results based on Student’s t-test analyses. Error bars
represent standard deviation from at least three independent experiments. Abbreviations: Pic, piceatannol; C, mESCs transfected with GFP expressing plasmid; Zap70OE,
mESCs transfected with Zap70 expressing plasmid; siShp2, siRNA targeting Shp2; siNS, non-speciﬁc siRNA.
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Fig. 4. Proposed model of ZAP70 and SHP2 activity in mESCs. ZAP70 phosphorylates
Tyr580 of SHP2 to activate phosphatase activity of SHP2, which subsequently leads
to the dephosphorylation of STAT3, as well as activation of the ERK pathway and
consequent suppression of LIFR protein level. The binary activity of SHP2 thus
inﬂuences ‘‘stemness” in mESCs.
4246 Y. Cha, K.-S. Park / FEBS Letters 584 (2010) 4241–4246experiment revealed that Zap70 is expressed in undifferentiated
hESCs (data not shown), it will be of great interest to elucidate
whether ZAP70 is an upstream regulator of SHP2 in hESCs to reg-
ulate the switch between pluripotency and differentiation of the
cells.
Phosphorylation of ERK1/2 is enhanced upon Zap70 overexpres-
sion, which suggests that ERK1/2 is not the direct target of SHP2.
Because Sprouty, which is a conserved inhibitor of the Ras-MAP ki-
nase signaling pathway, is a known target of SHP2 [21], it will be
important to elucidate whether SHP2 functions as a positive regu-
lator of ERK1/2 pathway by inactivating Sprouty protein in mESCs.
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